Phagenyx® Registry Study: Evaluating Swallowing Therapy Outcomes and Recovery in the U.S.
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
A retrospective, open-label, matched-control registry study designed to characterize the effectiveness of Pharyngeal Electrical Stimulation (PES) to improve swallowing in patients with severe dysphagia post stroke when delivered using the Phagenyx® System in real-world clinical settings in hospitals in the United States of America (US).
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Phagenyx® System Group Patients: Patients underwent treatment with the Phagenyx® System for a minimum of 3 treatments.
• Control Group Patients: Patient requires a nasogastric feeding tube for severe dysphagia and required dysphagia treatment.
• Willing and able to provide appropriate informed consent (if required).
Locations
United States
Arizona
Banner University Medical Center
RECRUITING
Phoenix
New Jersey
HMH Jersey Shore University Medical Center
RECRUITING
Neptune City
Texas
University of Texas
RECRUITING
Houston
Contact Information
Primary
Jennifer Miller
jennifer.miller@phagenesis.com
248-420-3292
Time Frame
Start Date: 2025-09-15
Estimated Completion Date: 2036-09
Participants
Target number of participants: 600
Treatments
Control Group
Patient requires a nasogastric feeding tube for severe dysphagia and required dysphagia treatment
Treatment Group
Patients who have undergone PES treatment for severe dysphagia.
Related Therapeutic Areas
Sponsors
Leads: Phagenesis Ltd.